Skip to main content

Table 1 Summary of the three randomization groups and the controlled levels of drug adherence

From: A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

Randomized Groups

Level of Adherence

Controlled Intake of Truvada

Group 1

(n = 10)

‘Perfect’ Adherence

(Daily)

Single tablet of Truvada® once daily for 6 weeks

Group 2

(n = 10)

‘Moderate’ Adherence

(4 times/week)

Single tablet of Truvada® 4 times per week (Monday, Wednesday, Friday and Saturday) for 6 weeks

Group 3

(n = 10)

‘Poor’ Adherence

(2 times/week)

Single tablet of Truvada® 2 times per week (Monday, Thursday) for 6 weeks